NanoGroup S.A. Logo

NanoGroup S.A.

Develops patented nanotechnology for oncology and transplantology diagnostics and therapies.

NNG | WAR

Overview

Corporate Details

ISIN(s):
PLNNGRP00011 (+3 more)
LEI:
259400HXWEAZUWRLY648
Country:
Poland
Address:
Warszawa Rakowiecka 36, 02-532 Warszawa
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

NanoGroup S.A. is a biotechnology company that develops and commercializes innovative medical solutions based on its unique, patented nanotechnology. The group's research and development work is concentrated on addressing critical medical needs, primarily in the fields of oncology and transplantology. Key projects include the development of nanoformulations for anticancer drugs, a fluid for the storage of organs intended for transplantation, nanoparticles for diagnostics and therapy, and a human blood substitute. The company operates through specialized subsidiaries, such as nanoSanguis and nanoVelos, to advance its distinct technological platforms and bring new medical technologies to market.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-10-06 16:58
Board/Management Information
Oświadczenie
Polish 156.9 KB
2025-10-06 16:58
Board/Management Information
Życiorys
Polish 324.7 KB
2025-10-06 16:58
Board/Management Information
Zgłoszenie kandydata na Członka Rady Nadzorczej NANOGROUP S.A. - Content (PL)
Polish 766 bytes
2025-10-06 12:47
Board/Management Information
Oświadczenie
Polish 131.2 KB
2025-10-06 12:47
Board/Management Information
Życiorys
English 199.3 KB
2025-10-06 12:47
Board/Management Information
Zgłoszenie kandydata na Członka Rady Nadzorczej NANOGROUP S.A. - Content (PL)
Polish 780 bytes
2025-10-01 17:02
Related Party Transaction
Powiadomienie
Polish 4.4 KB
2025-10-01 17:02
Major Shareholding Notification
Powiadomienie o transakcji, o którym mowa w art. 19 ust. 1 rozporządzenia MAR -…
Polish 545 bytes
2025-10-01 16:53
Director's Dealing
Powiadomienie
Polish 4.3 KB
2025-10-01 16:53
Director's Dealing
Powiadomienie o transakcji, o którym mowa w art. 19 ust. 1 rozporządzenia MAR -…
Polish 469 bytes
2025-09-25 18:33
Audit Report / Information
Raport audytora
Polish 647.6 KB
2025-09-25 18:33
Interim Report
Sprawozdanie
Polish 1.1 MB
2025-09-25 18:23
Audit Report / Information
Opinia Rady Nadzorczej
Polish 56.6 KB
2025-09-25 18:23
Management Discussion and Analysis
Stanowisko Zarządu
Polish 325.8 KB
2025-09-25 18:23
Audit Report / Information
Raport audytora
Polish 636.8 KB

Automate Your Workflow. Get a real-time feed of all NanoGroup S.A. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for NanoGroup S.A. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
HYUNDAI BIOLAND Co.,Ltd. Logo
Develops natural biomaterials for cosmetics, nutraceuticals, and regenerative medicine globally.
South Korea 052260
Icure Pharmaceutical Incorporation Logo
Develops transdermal patches for dementia/Parkinson's and offers cosmetic ODM/OBM services.
South Korea 175250
Idorsia Ltd Logo
Develops and commercializes small-molecule medicines for CNS, cardiovascular, and immune disorders.
Switzerland IDIA
IL DONG PHARMACEUTICAL CO., LTD. Logo
Develops & manufactures pharmaceuticals, APIs, and offers CMO services for various diseases.
South Korea 249420
ILSUNG IS CO., LTD. Logo
Develops pharmaceuticals like antibiotics and anesthetics, expanding into CNS and GI therapies.
South Korea 003120
ILYANG PHARMACEUTICAL CO.,LTD Logo
Develops & manufactures drugs, vaccines & supplements for oncology & gastroenterology needs.
South Korea 007570
ImmuneOncia Therapeutics, Inc. Logo
A biopharma firm developing immune checkpoint inhibitors for cancer immunotherapy.
South Korea 424870
Immuno-Biological Laboratories Co., Ltd. Logo
Develops and supplies immunological reagents and diagnostics for research and drug discovery.
Japan 4570
Develops targeted dermatology & oncology therapies using unique formulation & delivery technologies.
United Kingdom N/A
Indivior PLC Logo
Develops pharmaceuticals for opioid use disorder, addiction, and serious mental illnesses.
United Kingdom INDV

Talk to a Data Expert

Have a question? We'll get back to you promptly.